Significance of dopamine D1 receptor signalling for steroidogenic differentiation of human induced pluripotent stem cells

[1]  S. Yamanaka,et al.  Efficient and Rapid Induction of Human iPSCs/ESCs into Nephrogenic Intermediate Mesoderm Using Small Molecule-Based Differentiation Methods , 2014, PloS one.

[2]  Chad A. Cowan,et al.  Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells , 2013, Nature Communications.

[3]  Kazuwa Nakao,et al.  Differentiation of human embryonic stem cells and human induced pluripotent stem cells into steroid-producing cells. , 2012, Endocrinology.

[4]  R. Gainetdinov,et al.  The Physiology, Signaling, and Pharmacology of Dopamine Receptors , 2011, Pharmacological Reviews.

[5]  N. Prabhakar,et al.  Post‐translational modification of glutamic acid decarboxylase 67 by intermittent hypoxia: evidence for the involvement of dopamine D1 receptor signaling , 2010, Journal of neurochemistry.

[6]  S. Schreiber,et al.  A small molecule that directs differentiation of human ESCs into the pancreatic lineage. , 2009, Nature chemical biology.

[7]  B. O'dowd,et al.  Calcium Signaling by Dopamine D5 Receptor and D5-D2 Receptor Hetero-Oligomers Occurs by a Mechanism Distinct from That for Dopamine D1-D2 Receptor Hetero-Oligomers , 2009, Molecular Pharmacology.

[8]  A. McMahon,et al.  Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. , 2008, Developmental biology.

[9]  T. Yanase,et al.  Adipose tissue-derived and bone marrow-derived mesenchymal cells develop into different lineage of steroidogenic cells by forced expression of steroidogenic factor 1. , 2008, Endocrinology.

[10]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[11]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[12]  K. Ohe,et al.  Steroidogenic factor 1/adrenal 4 binding protein transforms human bone marrow mesenchymal cells into steroidogenic cells. , 2007, Journal of molecular endocrinology.

[13]  S. Chueh,et al.  Down-regulation of D2 dopamine receptor and increased protein kinase Cmu phosphorylation in aldosterone-producing adenoma play roles in aldosterone overproduction. , 2007, The Journal of clinical endocrinology and metabolism.

[14]  J. Tena,et al.  Odd-skipped genes encode repressors that control kidney development. , 2007, Developmental biology.

[15]  E. Kroon,et al.  Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells , 2006, Nature Biotechnology.

[16]  K. Huber.  The sympathoadrenal cell lineage: specification, diversification, and new perspectives. , 2006, Developmental biology.

[17]  Kazuya Yamada,et al.  Differentiation of adult stem cells derived from bone marrow stroma into Leydig or adrenocortical cells. , 2006, Endocrinology.

[18]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[19]  K. Ohe,et al.  Differentiation and regeneration of adrenal tissues: An initial step toward regeneration therapy for steroid insufficiency. , 2006, Endocrine journal.

[20]  R. James,et al.  Odd-skipped related 1 is required for development of the metanephric kidney and regulates formation and differentiation of kidney precursor cells , 2006, Development.

[21]  G. Hammer,et al.  Minireview: transcriptional regulation of adrenocortical development. , 2005, Endocrinology.

[22]  T. Yanase,et al.  SF‐1/Ad4BP transforms primary long‐term cultured bone marrow cells into ACTH‐responsive steroidogenic cells , 2004, Genes to cells : devoted to molecular & cellular mechanisms.

[23]  T. MacDonald,et al.  Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease , 2004, Annals of Internal Medicine.

[24]  S. Lamberts,et al.  Dopamine receptor expression and function in human normal adrenal gland and adrenal tumors. , 2004, The Journal of clinical endocrinology and metabolism.

[25]  Khusru Asadullah,et al.  Mechanisms involved in the side effects of glucocorticoids. , 2002, Pharmacology & therapeutics.

[26]  S. Chueh,et al.  Expression and localization of human dopamine D2 and D4 receptor mRNA in the adrenal gland, aldosterone-producing adenoma, and pheochromocytoma. , 2001, The Journal of clinical endocrinology and metabolism.

[27]  J. Reig,et al.  Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. , 2000, Diabetes.

[28]  S. Shepherd,et al.  Frog chromaffin and Adrenocortical Cell Co‐Cultures: A Model for the Study of Medullary Control of Corticosteroidogenesis , 1998, Journal of neuroendocrinology.

[29]  L. Conforti,et al.  Expression of dopamine D2 receptor in PC-12 cells and regulation of membrane conductances by dopamine. , 1997, American journal of physiology. Cell physiology.

[30]  J. Milbrandt,et al.  Nuclear receptor steroidogenic factor 1 directs embryonic stem cells toward the steroidogenic lineage , 1997, Molecular and cellular biology.

[31]  S. Mesiano,et al.  Developmental and functional biology of the primate fetal adrenal cortex. , 1997, Endocrine reviews.

[32]  K. Morohashi,et al.  Identical origin of adrenal cortex and gonad revealed by expression profiles of Ad4BP/SF‐1 , 1996, Genes to cells : devoted to molecular & cellular mechanisms.

[33]  F. Amenta,et al.  Pharmacological characterization and autoradiographic localization of dopamine receptors in the human adrenal cortex. , 1994, European Journal of Endocrinology.

[34]  R. Donald,et al.  Bone mineral density is reduced in female but not male subjects with Addison's disease. , 1994, The New Zealand medical journal.

[35]  P. V. van Rijk,et al.  Effect of Glucocorticoid Replacement Therapy on Bone Mineral Density in Patients with Addison Disease , 1994, Annals of Internal Medicine.

[36]  J. Avorn,et al.  Glucocorticoids and the risk for initiation of hypoglycemic therapy. , 1994, Archives of internal medicine.

[37]  R. Carey,et al.  Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone. , 1979, The Journal of clinical investigation.

[38]  S. Shepherd,et al.  Chromaffin-adrenocortical cell interactions: effects of chromaffin cell activation in adrenal cell cocultures. , 2001, American journal of physiology. Cell physiology.

[39]  S. Bornstein,et al.  Basal steroidogenic activity of adrenocortical cells is increased 10-fold by coculture with chromaffin cells. , 1998, Endocrinology.